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Abstract
Background: A PCR-enzyme-linked immunosorbent assay (PCR-ELISA) was developed to overcome the need for sensitive
techniques for the efficient diagnosis of Schistosoma infection in endemic settings with low parasitic burden.
Methodology/Principal Findings: This system amplifies a 121-base pair tandem repeat DNA sequence, immobilizes the
resultant 59 biotinylated product on streptavidin-coated strip-well microplates and uses anti-fluorescein antibodies
conjugated to horseradish peroxidase to detect the hybridized fluorescein-labeled oligonucleotide probe. The detection
limit of the Schistosoma PCR-ELISA system was determined to be 1.3 fg of S. mansoni genomic DNA (less than the amount
found in a single cell) and estimated to be 0.15 S. mansoni eggs per gram of feces (fractions of an egg). The system showed
good precision and genus specificity since the DNA target was found in seven Schistosoma DNA samples: S. mansoni, S.
haematobium, S. bovis, S. intercalatum, S. japonicum, S. magrebowiei and S. rhodaini. By evaluating 206 patients living in an
endemic area in Brazil, the prevalence of S. mansoni infection was determined to be 18% by examining 12 Kato-Katz slides
(41.7 mg/smear, 500 mg total) of a single fecal sample from each person, while the Schistosoma PCR-ELISA identified a 30%
rate of infection using 500-mg of the same fecal sample. When considering the Kato-Katz method as the reference test,
artificial sensitivity and specificity rates of the PCR-ELISA system were 97.4% and 85.1%, respectively. The potential for
estimating parasitic load by DNA detection in feces was assessed by comparing absorbance values and eggs per gram of
feces, with a Spearman correlation coefficient of 0.700 (P,0.0001).
Conclusions/Significance: This study reports the development and field evaluation of a sensitive Schistosoma PCR-ELISA, a
system that may serve as an alternative for diagnosing Schistosoma infection.
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Introduction
Schistosomiasis affects 200 million people and about 779
million people live in endemic areas in the Middle East, South
America, Caribbean, Southeast Asia and particularly sub-
Saharan Africa [1]. Population- and treatment-based control
programs have been successful in reducing the intensity of
infection and severe morbidities associated with schistosomiasis;
however, transmission remains active in highly endemic areas,
and recurring low-level reinfection is likely to be associated with
subtle but persistent morbidities such as anemia, malnutrition and
diminished performance status [2–4]. In the presence of these
conditions, the assessment of infection becomes less reliable since
the currently used diagnostic methods are not sufficiently sensitive
to accurately determine the prevalence of schistosomiasis or
parasite burden in order to eventually achieve elimination of the
disease [5,6].
Microscopic demonstration of the parasite’s eggs in feces or urine
remains the most wide-spread tool for schistosomiasis diagnosis. The
Kato-Katz technique [7] is currently the most used method for fecal
examination because it is quantitative, relatively inexpensive and
simple. A significant increase in the sensitivity of the method is gained
by microscopic examination of multiple samples [8,9], but this is a
limiting procedure for field work.
To overcome the current limitations with respect to diagnosis,
the simultaneous use of different diagnostic methods, such as
antibody detection followed by stool examination of seropositive
individuals, has been applied to monitor the human population
and to identify the small number of infected people once morbidity
control is achieved [6]. However, because antibody detection
methods often cannot distinguish between current and past
infection and may also present a high level of crossreactivity,
molecular tools should be considered despite their higher cost and
the requirement for special laboratory equipment [10].
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repeat DNA sequence present in 12% of Schistosoma mansoni
genome. This sequence has been successfully used in PCR-based
approaches for the detection of the parasite in snails [12],
monitoring of cercariae in water bodies [13] and diagnosis of
human infection using fecal or serum samples [14] and, more
recently, plasma samples [15]. In a population study, the
prevalence of S. mansoni infection was determined to be 31%
when three fecal samples were examined using the Kato-Katz
technique, but the prevalence rose to 38% when the PCR
technique developed by Pontes et al. [14] was employed using
only one fecal sample [16]. The same result was observed by
another group in a recent study assessing the marginal error of
Kato-Katz examinations for diagnosis and cure evaluation of S.
mansoni infection in areas of low endemicity [17].
Conventional PCR requires several steps after DNA amplifica-
tion, including electrophoresis or blotting and hybridization, which
are limited in the number of samples that can be conveniently
analyzed. The PCR-enzyme-linked immunosorbent assay (PCR-
ELISA) consists of an alternative process for large-scale screening
that allows for semi-quantitative analysis. This technique combines
an immunological method to quantify the PCR product directly
after immobilization of biotinylated DNA on a microplate [18,19].
The advantage of PCR-ELISA as compared to PCR-electropho-
resis is that it makes use of standard equipment widely used for the
processing of ELISAs, and the reagents used are easy to obtain
commercially. Therefore, PCR-ELISA allows for the use of PCR-
based DNA diagnosis for routine purposes in laboratories in less
developed countries with fewer resources.
The aim of this work was to design a Schistosoma PCR-ELISA
system as an improvement over the PCR assay previously
developed by our group to detect S. mansoni DNA in human fecal
samples [14]. The performance of the new assay was evaluated
with fecal specimens from a Brazilian endemic area for S. mansoni
infection and compared with the parasitological Kato-Katz
technique for detection and estimation of the intensity of
infection.
Materials and Methods
S. mansoni eggs and artificial egg-spiked fecal samples
For use throughout the development of the Schistosoma PCR-
ELISA system and for the estimation of its lower detection limit, S.
mansoni eggs were obtained from the livers of Swiss albino mice 60
days after infection with 150 cercariae and stored at 220uCi n
1.7% saline until use [20]. The animals were handled according to
local and federal regulations, and the research protocol was
approved by the Fiocruz Committee on Animal Research (License
L-0118/09).
The number of eggs in saline suspension was quantified using a
Neubauer chamber, and a solution containing approximately
2,000 eggs was used for DNA extraction. A negative fecal sample
(verified to be free of S. mansoni eggs by the Kato-Katz technique
and negative for the Schistosoma DNA detection by the PCR-
ELISA system) was spiked with the egg-saline solution. The egg
count was assessed by the Kato-Katz method, and approximately
500 mg of screened feces were used for DNA extraction.
DNA from other Schistosoma species
Samples of genomic DNA from the human parasites S.
haematobium, S. intercalatum and S. japonicum, and also from S. bovis,
S. magrebowiei and S. rhodaini were provided by the Laborato ´rio de
Parasitologia Celular e Molecular (Centro de Pesquisas Rene ´
Rachou, Fiocruz, Brazil) and used to assess the genus specificity of
the Schistosoma PCR-ELISA system.
Study population
Two hundred and six people from Pedra Preta, Minas Gerais,
Brazil, an endemic area for S. mansoni infection, participated in this
study. The group was composed of 69 children (female/male: 33/
36; age range of 1–17 years) and 137 adults (female/male: 66/71;
age range of 18–86 years). Thirty-six healthy members of the
laboratory staff participated as negative controls throughout the
development of the assay. Written informed consent was obtained
from all adult participants and from parents or legal guardians of
minors. This study was approved by the Ethics Committee of the
Centro de Pesquisas Rene ´ Rachou, Fiocruz, Brazil (No. 14/2008).
For PCR-ELISA, fecal samples were collected and stored at
270uC until DNA extraction. All samples were evaluated for the
presence of S. mansoni eggs by the Kato-Katz method. Twelve glass
slides (41.7 mg/smear) of a single fecal sample were examined,
resulting in a total sample weight of about 500 mg. Egg counts
were expressed in eggs per gram of feces (epg), using the arithmetic
mean of eggs counts obtained from the 12 slides multiplied by 24
[7]. The intensity of infection was calculated as the geometric
mean of the individual egg counts.
Individuals with positive fecal examination results were treated
with a single oral dose of praziquantel (50 or 60 mg/kg for adults
and children, respectively), according to the recommendation of
the Brazilian Ministry of Health.
DNA extraction
Total DNA from 500 mg of each fecal sample and the DNA
from a saline solution containing approximately 2,000 S. mansoni
eggs were extracted using the QIAamp DNA Stool Mini Kit
(Qiagen GmbH, Hilden, Germany), according to the manufac-
turer’s recommendations and following the protocols ‘‘DNA
Isolation from Large Amounts of Stool’’ and ‘‘Isolation of DNA
from Stool for Pathogen Detection’’. The heating step was
performed at 95uC for 20 min to guarantee egg rupture. The
concentration and purity of the DNA were determined spectro-
Author Summary
Schistosomiasis is a neglected disease caused by worms of
the genus Schistosoma. The transmission cycle requires
contamination of bodies of water by parasite eggs present
in excreta, specific snails as intermediate hosts and human
contact with water. Fortunately, relatively safe and easily
administrable drugs are available and, as the outcome of
repeated treatment, a reduction of severe clinical forms
and a decrease in the number of infected persons has
been reported in endemic areas. The routine method for
diagnosis is the microscopic examination but it fails when
there are few eggs in the feces, as usually occurs in treated
but noncured persons or in areas with low levels of
transmission. This study reports the development of the
PCR-ELISA system for the detection of Schistosoma DNA in
human feces as an alternative approach to diagnose light
infections. The system permits the enzymatic amplification
of a specific region of the DNA from minute amounts of
parasite material. Using the proposed PCR-ELISA approach
for the diagnosis of a population in an endemic area in
Brazil, 30% were found to be infected, as compared with
the 18% found by microscopic fecal examination. Al-
though the technique requires a complex laboratory
infrastructure and specific funding it may be used by
control programs targeting the elimination of schistoso-
miasis.
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Hamburg, Germany).
Primers and probes
The Schistosoma PCR-ELISA system consisted of a biotin 59-
labeled forward primer (59-GATCTGAATCCGACCAACCG-
39), an unlabeled reverse primer(59-ATATTAACGCC-
CACGCTCTC-39) and the fluorescein 59-labeled probe (59-
TGGTTTCGGAGATACAACGA-39). The primers used were
previously described [14] and designed to amplify a 121-bp
tandem repeat DNA sequence (GenBank accession number
M61098) found in the genome of S. mansoni [11].
To control for variation in the efficiency of DNA extraction and
PCR-amplification, all clinical samples were evaluated with the
human beta actin PCR-ELISA system. The primers used were
Aco1 (59-ACCTCATGAAGATCCTCACC-39) and Aco2 (59-
CCATCTCTTGCTCGAAGTCC-39), which were previously
described to target the fourth exon of the human beta actin gene
(ACTB) [21]. In this assay, the sense primer (Aco1) was
biotinylated at the 59 end, and a fluorescein 59-labeled probe
(59-TCTCCTTAATGCACGCACG-39) was designed together
with the Schistosoma probe described above using the program
Primer3-web 0.4.0 [22] and submitted to homology searches on
the National Center for Biotechnology Information website with
nucleotide BLAST program using database Nucleotide collection
(nr/nt) and Megablast option. Amplification primers, biotinylated
primers and probes were purchased from Integrated DNA
Technologies, Inc. (Coralville, Iowa, USA).
PCR conditions
For amplification, fecal DNA samples were diluted fivefold, and
2 ml were used as the template. The same volume was used to
amplify S. mansoni egg-derived DNA, artificial S. mansoni egg-spiked
fecal DNA and DNA from other Schistosoma species. PCR was
carried out in a final volume of 20 ml containing 2 ml of GeneAmp
10X PCR Gold Buffer (150 mM Tris-HCl, pH 8.0, 500 mM
KCl), 2.0 U of Amplitaq Gold (Applied Biosystems, Foster City,
CA, USA), 0.1 mg/ml of BSA (Sigma, St. Louis, MO, USA),
0.5 mM of each primer, 1.5 mM MgCl2 and 200 mM of each
deoxynucleoside triphosphate (Promega, Madison, WI, USA). The
cycling programs, preceded by 12 min at 95uC to activate the
HotStart Taq polymerase, consisted of 15 cycles of 95uC for 1 min,
63uC for 1 min and 72uC for 30 s; 12 cycles of 80uC for 1 min,
63uC for 1 min and 72uC for 30 s and 7 cycles of 80uC for 1 min,
65uC for 1 min and 72uC for 30 s, followed by a final elongation
step at 72uC for 7 min. Positive controls based on DNA from S.
mansoni eggs were included in all tests. Negative controls containing
all of the elements of the reaction mixture except DNA were also
included in each PCR assay as surveillance for contamination.
A 120-bp segment of the ACTB gene was amplified in a separate
tube containing fecal DNA, following the amplification protocol
described above, except that the MgCl2 concentration used was
2 mM. The cycling program, preceded by 12 min at 95uC,
consisted of 35 cycles of 95uC for 20 s, 60uC for 30 s and 72uC for
1 min, followed by a final elongation step at 72uC for 7 min.
The chance of PCR contamination was minimized by physical
separation of the starting materials and the amplified products in
different rooms; the rooms contained laminar flux chambers with
UV light, and sterile, disposable laboratory supplies were used.
Detection of PCR products
(i) Electrophoresis. Five microliters of PCR-amplified egg-
derived DNA, artificial egg-spiked fecal DNA and DNA from
other Schistosoma species were subjected to electrophoresis on 6%
polyacrylamide gels and analyzed by silver staining.
(ii) ELISA. For the Schistosoma PCR-ELISA system, the
detection of the biotin-labeled amplified DNA was carried out
using the PCR Plate Detection Kit (Sigma, St. Louis, MO, USA),
according to the manufacturer’s recommendations. Briefly,
samples (5 ml of PCR product mixed with 95 ml of dilution
buffer) were added in triplicate to streptavidin-coated wells, and
the plate was incubated at 37uC for 30 min. Denaturation solution
was added to a final volume of 100 ml and incubated for 10 min
at room temperature. After four washes with PBS-Tween 20
washing solution (PBS-T), 200 ml of PlateHyb hybridization buffer
containing 0.2 pmol of fluorescein 59-labeled probe and 20% of
formamide was added to each well for incubation at 37uC
for 45 min. The plate was then washed five times with
PBS-T solution. Anti-fluorescein-horseradish peroxidase (HRP)
conjugated antibody, diluted 500-fold in PBS-T solution, was
added to each well in a final volume of 150 ml, and then the plate
was incubated at 37uC for 45 min. The plate was again washed
five times with PBS-T solution. TMB Liquid Substrate System was
added to each well to a final volume of 100 ml, and the plate was
incubated at room temperature for 5 min, kept in the dark during
color development. Finally, 50 ml of stop solution provided by the
commercial kit was added, and absorbance at 450 nm was
determined in an ELISA reader (Bio-Rad, Hercules, CA, USA).
Each PCR-ELISA reaction was performed with positive (DNA
extracted from S. mansoni eggs) and negative controls (water and
PCR negative control). All experiments were performed in
triplicate, and data represent mean values. The cut-off value was
calculated as the mean absorbance value of the negative controls
(20 healthy persons from the laboratory staff) plus three standard
deviations, as obtained with a single PCR-ELISA test [23]. As
the mean absorbance value and standard deviation were
0.08060.012, a sample was considered positive when the
absorbance of the three measurements was greater than 0.116
(the cut-off value).
The ACTB PCR-ELISA system followed the same conditions
described above, except that 10 ml of PCR product was used; the
hybridization protocol was performed at 50uC without the
addition of formamide, and the colorimetric substrate TMB
was reacted for 30 min at room temperature in the dark. The
cut-off value obtained for each PCR-ELISA test was calculated as
twice the mean absorbance value of the PCR negative control
[23].
Statistical analysis
Data were processed with SPSS statistical software package 13.0
for Windows (SPSS Inc., Chicago, IL, USA) and GraphPad Prism
3.0.3 software (San Diego, CA, USA). All quantitative variables
were individually assessed with the one-sample Kolmogorov-
Smirnov test for normality. Absorbance readings and arithmetical
means of the number of eggs per gram of feces and template DNA
concentration (both transformed into log scale) were analyzed by
Pearson’s parametric correlation coefficient or Spearman’s
nonparametric correlation coefficient. In order to determine the
variability of the assays, intra-assay (repeatability) and inter-assay
(reproducibility) precision levels were measured by comparing the
means 6 the S.D. and reported as coefficients of variation (CVs,
S.D./mean X 100%). Sensitivity, specificity and 95% confidence
intervals (CIs) were calculated using the OpenEpi Version 2.3
program [24]. Agreement beyond chance was assessed using the
Kappa index and interpreted according to Landis and Koch [25]:
1.00-0.81 is excellent, 0.80-0.61 is good, 0.60-0.41 is moderate,
0.40-0.21 is weak and 0.20-0.0 is negligible. The X
2 test was
PCR-ELISA System for Schistosoma Detection
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significance was set at P,0.05.
Results
Schistosoma PCR-ELISA system development
The system’s analytical sensitivity was evaluated using eight 10-
fold serial dilutions ranging from 1.3 ng to 130 ag of genomic
DNA extracted from a saline solution containing S. mansoni eggs.
The limit of detection was 1.3 fg of genomic DNA, equal to that
obtained by 6% polyacrylamide gel electrophoresis and silver
staining, since the absorbance value for the sample with 130 ag of
DNA was equivalent to the PCR negative control (0.093 and
0.064, respectively) (Figure 1A). The correlation between the
numeric results (optical density readings) of the PCR-ELISA and
the log number of the template DNA was significant, with a
Pearson’s correlation coefficient of 0.986 (P,0.0001) (Figure 1B).
The analytical sensitivity of the assay was also evaluated with 10-
fold dilutions of DNA extracted from a negative fecal sample
spiked with an S. mansoni egg-saline solution determined by the
Kato-Katz method to contain 1,534 epg. The Schistosoma PCR-
ELISA system was consistently able to detect a sample estimated to
contain 0.1534 epg.
The genus specificity of PCR-ELISA was assessed with purified
DNA from S. mansoni, S. haematobium, S. bovis, S. intercalatum, S.
japonicum, S. magrebowiei and S. rhodaini adult worms. Results
(Figure 2) showed a ladder of PCR products due the amplification
of the Schistosoma tandem-repeated unit, with the main DNA band
of 110 bp present in all samples, as expected, and absorbance
readings comparable to the positive control (S. mansoni DNA).
To analyze the repeatability of the Schistosoma PCR-ELISA
system, three positive and three negative fecal samples from
patients were assessed in four replicates in a single run. The intra-
assay CVs for absorbance values for the negative samples were:
5.6%, 7.4% and 8.3%; the CVs for the positive samples were
1.9%, 3.6% and 4.2%. In addition, to measure the reproducibility,
four replicates of the same samples were assessed on different days
in four different assays. The inter-assay variations of absorbance
values for the positive DNA samples were 3.8%, 7.7% and 15.9%;
the variations for the negative DNA samples were 14.2%, 15.4%
and 18.7%.
Analysis of patient samples
Fecal samples from 206 patients from an area in Brazil endemic
for S. mansoni were analyzed by the Schistosoma PCR-ELISA system
and also by the parasitological Kato-Katz technique. Comparison
of the results obtained by the Schistosoma PCR-ELISA system and
the Kato-Katz technique, based on examination of twelve slides (a
total of 500 mg feces), is shown in Table 1. The geometric mean of
the number of eggs per gram of feces estimated by the Kato-Katz
technique for the positive samples was 18, which indicates a low
intensity of infection [26]. The prevalence observed using the
PCR-ELISA system (30%) was higher than that determined with
the examination of twelve slides by the Kato-Katz technique (18%)
Figure 1. Analytical sensitivity of PCR-ELISA system. A. Analytical sensitivity of PCR followed by 6% polyacrylamide gel electrophoresis with
silver staining and ELISA (optical density, OD) for 10-fold serial dilutions of genomic DNA extracted from a saline solution containing ,2,000 S.
mansoni eggs. The detection limit was 1.3 fg of genomic DNA. A ladder-type banding pattern was exhibited, as expected, due the amplification of
the Schistosoma tandem-repeated unit, with the main DNA band of 110 bp present in all samples. B. The Pearson’s correlation coefficient between
PCR-ELISA OD and log[template DNA]+10 was 0.986 (P,0.0001).
doi:10.1371/journal.pntd.0000664.g001
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2=8.81, P,0.003). The Kappa index of 0.663 indicates good
agreement between the two methods. Analysis of discordant results
showed that 25 samples were positive only by the Schistosoma PCR-
ELISA system, and one sample was positive only by the Kato-Katz
technique. This patient had very low egg output (8 epg).
Table 1 also shows a comparison of the results obtained by the
Schistosoma PCR-ELISA system and the Kato-Katz technique,
based on examination of two slides (a total of 83.4 mg feces), as is
routinely done in epidemiological surveys. The Kappa index of
0.491 indicates a moderate agreement between the two methods.
Analysis of discordant results showed that 36 samples were positive
only by the Schistosoma PCR-ELISA system.
Diagnostic parameters were calculated by two different
approaches: 1) taking two-slide Kato-Katz examination as the
reference method for comparison or 2) considering twelve-slide
Kato-Katz examination as the reference method. The sensitivity
values of the Schistosoma PCR-ELISA system were high, regardless
of the reference considered: 96.3% (95% CI, 81.7–99.3) for
approach 1 and 97.4% (95% CI 86.5–99.5) for approach 2.
Specificity values changed significantly depending on the reference
used, being 79.9% (95% CI 73.4–85.1) for approach 1 and 85.1%
(95% CI 78.7–89.7) for approach 2.
All 206 fecal samples analyzed by the ACTB PCR-ELISA
system showed a positive result, ensuring that negative results
correspond to true negative samples for the Schistosoma PCR-
ELISA system rather than to a problem with sample degradation
or PCR inhibition. Also, the remaining sixteen fecal samples of
non-infected persons were evaluated to be positive for the ACTB
PCR-ELISA system and negative for the Schistosoma PCR-ELISA
system.
Potential for semi-quantitative use of the PCR-ELISA
system
The ability of the Schistosoma PCR-ELISA system to estimate the
parasitic load was assessed, and a Spearman’s correlation
coefficient of 0.616 (P,0.0001) was found when comparing values
of absorbance readings and epg (transformed into log[epg+1]) to
those determined by the Kato-Katz technique with 12 examined
slides (Figure 3A). When the correspondence between the methods
was evaluated, considering only positive and negative samples for
both, the correlation coefficient observed was 0.700 (P,0.0001)
(Figure 3B).
Results obtained with the Schistosoma PCR-ELISA system based
on two levels of intensity of infection (1–100 epg and .100 epg),
according to the Kato-Katz stool examination method, are shown
in Table 2. The high sensitivity of the Schistosoma PCR-ELISA
system was evidenced by the high number of positive samples in
both groups. The assay also revealed the potential to be considered
semi-quantitative, as the mean absorbance readings corresponded
to the intensity of infection.
Discussion
The control of schistosomiasis-related morbidity has become
feasible due to the development of single-dose oral drugs such as
oxamniquine and praziquantel, which are given to heavily
infected patients (high worm burden) that were easily detected
by field-applicable parasitological methods. With the transition to
lower morbidity, there is need for more sensitive diagnostic
methods. In an attempt to surpass this diagnostic limitation, a
PCR-ELISA system was developed and evaluated as a new
Figure 2. Analytical specificity of PCR followed by 6% polyacrylamide gel electrophoresis with silver staining and ELISA (optical
density, OD) for purified DNA from adult S. magrebowiei (lane 2), S. rhodaini (lane 3), S. japonicum (lane 4), S. intercalatum (lane 5), S.
haematobium (lane 6), S. bovis (lane 7) and S. mansoni (lane 8) worms. Lane 1, PCR negative control. The genus specificity of the Schistosoma
PCR-ELISA system was demonstrated by the amplification of the 121-bp tandem repeat DNA sequence in all samples with the same set of primers.
Absorbance readings were also consistent with the positive control (S. mansoni DNA).
doi:10.1371/journal.pntd.0000664.g002
Table 1. Comparative evaluation of the Schistosoma
PCR-ELISA system and the Kato-Katz technique for the
diagnosis of S. mansoni infection.
Positive Negative Total
Kato-Katz fecal examination (2 slides – 83 mg feces)
PCR-ELISA
Positive 26 36 62
Negative 1 143 144
Total 27 179 206
Kappa index=0.491
Kato-Katz fecal examination (12 slides – 500 mg feces)
PCR-ELISA
Positive 37 25 62
Negative 1 143 144
Total 38 168 206
Kappa index=0.663
doi:10.1371/journal.pntd.0000664.t001
PCR-ELISA System for Schistosoma Detection
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system showed sound features, such as a low analytical limit of
detection, genus specificity (and absence of cross-reactivity with
other related parasites), good precision, high sensitivity, good
specificity and also the potential for semi-quantitative analysis of
parasitic load.
Evaluation of the analytical sensitivity of the Schistosoma PCR-
ELISA system showed that it could accurately detect 1.3 fg of S.
mansoni genomic DNA, which is equivalent to less than the DNA
found in a single cell of this multicellular parasite, since its genome
contains around 580 fg [27]. The high sensitivity of the assay is
attainable due to the high copy number of the target sequence,
which comprises approximately 12% of the S. mansoni genome
[11]. In another approach, the analytical sensitivity was evaluated
as the capability to detect DNA samples according to the egg
count. The result obtained (0.1534 epg) corresponds to fractions of
an egg.
The Schistosoma PCR-ELISA system was developed using primers
designed by Pontes et al. [14], who demonstrated specificity by the
absence of amplification when DNA from four related helminths
(Ascaris lumbricoides, Ancylostoma duodenale, Taenia solium and Trichiuris
trichiura) was used as templates. Further assay also showed no
crossreactivity with Fasciola hepatica (data not shown). Additionally,
the potential use of the previously described primers and probe and
the current PCR protocol to detect genomic DNA from other
Schistosoma species was assessed by the amplification of DNA
extracted from worms of seven Schistosoma species (S. mansoni, S.
haematobium, S. bovis, S. intercalatum, S. japonicum, S. magrebowiei and S.
rhodaini). The results obtained confirmed what Hamburger et al.
[11] partially addressed using a different set of primers that targets
the internal part of the same DNA sequence: namely, this 121-bp
tandem repeat is genus specific.
The precision of the Schistosoma PCR-ELISA system can be
considered good, as the intra-assay variation was lower than 9%,
and the inter-assay variation was around 3% to 19%. These
percentages are similar to, or lower than, those calculated for other
PCR-ELISA assay based on similar principles [28].
The choice of a reference test is crucial for the evaluation of any
new testing method. The Kato-Katz technique is considered the
test of choice to diagnose schistosomiasis in fecal samples and was
chosen as a reference test for comparison with the Schistosoma
PCR-ELISA system. Initially, for a traditional approach (approach
1 in this study), the comparison was made using two Kato-Katz
slides, corresponding to 83.4 mg feces. The PCR-ELISA system
was able to detect S. mansoni DNA in 36 fecal samples from
patients with negative results by the Kato-Katz technique (two
slides examined), demonstrating high sensitivity (96.3%), though
lower specificity (79.9%). This specificity is likely to be artificial
and incorrect, resulting from the less sensitive and inadequate
reference method. In another approach (approach 2), twelve Kato-
Katz slides were evaluated, corresponding to 500 mg of feces, the
same quantity used to extract total DNA for analysis with the
Schistosoma PCR-ELISA system. Again, the PCR-ELISA system
detected more cases of infection with S. mansoni. Thus the
sensitivity was high (97.4%), and the specificity was more
satisfactory (85.1%). It is well documented that the Kato-Katz
method lacks sensitivity if only a single fecal sample is examined,
particularly in areas with high proportions of light-intensity
Figure 3. Correlation between log-transformed individual measurements of eggs per gram (epg) of feces and absorbance readings.
A. A Spearman’s correlation coefficient of 0.616 (P,0.0001) was found for a comparison considering all 206 samples. B. Considering positive and
negative samples for the Kato-Katz technique and the Schistosoma PCR-ELISA system, a Spearman’s correlation coefficient of 0.700 (P,0.0001) was
observed. The continuous line represents the linear regression, and the hatched line represents the 95% CI.
doi:10.1371/journal.pntd.0000664.g003
Table 2. Results obtained with the Schistosoma PCR-ELISA system grouped into two levels of intensity of infection.
Schistosoma PCR-ELISA system
Intensity of infection
a Number Negative Positive Positivity rate (%) Mean OD
b
Negative 168 143 25 14.9 0.069
1–100 epg 32 1 31 96.9 1.050
101+ epg 6 0 6 100 1.468
aIntensity of infection was based on examination of one fecal sample by the Kato-Katz technique (12 slides - 500 mg feces).
bConsidering only concordant results between the Kato-Katz technique and the Schistosoma PCR-ELISA system; OD = optical density.
doi:10.1371/journal.pntd.0000664.t002
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days or patchily distributed may not be detected in the small
amount of feces examined, negatively impacting on the method’s
sensitivity. In order to overcome these shortcomings, examination
of an increased number of fecal samples as well as in the number
of slides per specimen is required. There exists a general consensus
that two Kato-Katz slides for each of three fecal samples yield
enough sensitivity to obtain reliable data [29-32]. As this present
study is part of a wider study in the endemic area of Pedra Petra,
Minas Gerais, Brazil, three additional samples were collected on
different days and analyzed by two Kato-Katz slides each (data not
shown). From samples with discordant results between Kato-Katz
analysis (twelve slides examined) and the Schistosoma PCR-ELISA,
12 out of 25 (48%) were positive in subsequent Kato-Katz
examinations of additional samples. Therefore, a better explana-
tion for these discordant results is that the Schistosoma PCR-ELISA
system is more sensitive than the Kato-Katz technique considering
the same amount of stool examined. That is, these cases
correspond to S. mansoni-infected samples and not false-positive
results. Although carryover contamination is often difficult to
exclude as a cause of false-positive results in PCR-based diagnostic
assays, the strict measures taken to avoid it throughout the entire
handling and processing steps of the assay make the chances low.
Following both approaches, one sample was positive for the
Kato-Katz technique and negative for the Schistosoma PCR-ELISA
system. Since the parasitological method has an assumed
specificity of 100%, this result can be most reasonably attributed
to misdiagnosis by the PCR-ELISA. Inhibition of the amplification
reaction by fecal compounds and/or DNA degradation during
transportation of the sample from the field were considered the
most likely technical causes. However, they were subsequently
ruled out, as a positive result was obtained with the control ACTB
PCR-ELISA system. Therefore, a better explanation seems to be
the uneven distribution of a small quantity of eggs in the feces [33],
since the sample had a very low parasite load (8 epg).
ELISA methods for the detection of PCR products provide an
alternative to gel-based detection. Among other features, ELISAs
prevent possible subjective interpretations of PCR results due to
‘‘nonspecific products’’ or ‘‘bands of unknown origin.’’ The main
advantage of the procedure is the ability to process many samples
in parallel (e.g., the 96-well microplate format), using instrumen-
tation developed for processing ELISA for antibody detection. In
addition, the procedure takes less than 2.5 hours to be performed
(with the PCR Plate Detection Kit; Sigma).
The detection format of the commercial kit used here combines
methodological features of PCR-ELISA methods described by
Landgraf et al. [18] and Luneberg et al. [19]. Biotin-streptavidin
binding was used for immobilization of amplification products on
microtiter plates, taking advantage of the biotin moiety conjugated
to one PCR primer. Subsequent hybridization was carried out
with a fluorescein-labeled oligonucleotide probe, with the
advantage of confirming the specificity of the test and allowing
for detection by an anti-fluorescein-HRP conjugate.
Regardlessof the fact that real-time PCRprovides the best means
to quantify PCR products, PCR-ELISA also allows for quantifica-
tion, although it is usually considered a semi-quantitative technique,
as it analyzes end-point amplification products. At the end-point,
net synthesis is significantly reduced, inhibitory effects have
accumulated and differences in initial starting template concentra-
tions are masked [34]. These problems may be overcome by
stopping the reaction in the exponential phase (as was done in the
present study) or by requiring competitive amplification with very
similar template DNA and primer pairs [18].
One classification used for epidemiological estimates of the
intensity of infection of schistosomiasis on a community level
considers the following groups: i) light, #100 eggs/gram of feces; ii)
moderate, 101 to 400 eggs/gram of feces and iii) heavy, .400 eggs/
gram of feces [26]. Even though the PCR-ELISA system developed
in this study showed a satisfactory correlation coefficient between
absorbance readings and egg counts per gram of feces, it seemed to
be adequate to classify the samples according to the same
parameters. However, as the performance of this new assay was
evaluated in a low endemic setting, the number of samples with high
egg counts was small, limiting statistical analysis. Thus, a statistically
significant difference between mean absorbance values was observed
only between the positive and negative groups (P,0.0001 for all).
Nevertheless, an increase in the mean absorbance readings with
increasing intensityofinfectioncouldbeobserved.Additionalstudies
in areas of higher prevalence, resulting in a statistically significant
numberofpatientswithhigheggcountspergramoffeces,needtobe
carried out in order to validate the Schistosoma PCR-ELISA system’s
semi-quantitative potential.
The choice of a molecular method for diagnosing Schistosoma
infection in endemic settings will depend on different factors,
chiefly the available infrastructure and the cost-effectiveness. A
control program may decide between performing multiple sample
collections for the Kato-Katz examination or carrying out a single
PCR-ELISA test, being the former less costly and the last more
accurate. Considering only reagents, the cost of the PCR-ELISA
system is roughly US$10 per fecal sample.
In conclusion, the Schistosoma PCR–ELISA system constitutes a
precise tool for the diagnosis of Schistosoma infection, which may be
particularly useful in low-prevalence settings and probably for
post-treatment situations.
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